CAP Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
CAP Partners's ABBV Position: Q3 2024 in Review
CAP Partners sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 2,206 shares — an estimated $378K sold.
CAP Partners first reported a position in ABBV in Q4 2023 and held it in 3 quarters. The position peaked at $406K in Q1 2024. 3,512 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- CAP Partners reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
- CAP Partners sold 2,206 AbbVie shares in Q3 2024, an estimated $378K.
- CAP Partners first reported a position in AbbVie in Q4 2023 and held it in 3 quarters.
- CAP Partners's AbbVie position peaked at $406K in Q1 2024.
- 3,512 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on CAP Partners's 13F filing for Q3 2024, filed 7 Nov 2024.